Changes in capsule and drug resistance of Pneumococci after introduction of PCV7, Japan, 2010-2013

Emerg Infect Dis. 2014 Jul;20(7):1132-9. doi: 10.3201/eid2007.131485.

Abstract

We aimed to clarify changes in serotypes and genotypes mediating β-lactam and macrolide resistance in Streptococcus pneumoniae isolates from Japanese children who had invasive pneumococcal disease (IPD) after the 7-valent pneumococcal conjugate vaccine (PCV7) was introduced into Japan; 341 participating general hospitals conducted IPD surveillance during April 2010-March 2013. A total of 300 pneumococcal isolates were collected in 2010, 146 in 2011, and 156 in 2012. The proportion of vaccine serotypes in infectious isolates decreased from 73.3% to 54.8% to 14.7% during the 3 years. Among vaccine serotype strains, genotypic penicillin-resistant S. pneumoniae strains also declined each year. Among nonvaccine serotype strains, 19A, 15A, 15B, 15C, and 24 increased in 2012. Increases were noted especially in genotypic penicillin-resistant S. pneumoniae isolates of serotypes 15A and 35B, as well as macrolide resistance mediated by the erm(B) gene in 15A, 15B, 15C, and 24.

Keywords: 13-valent pneumococcal conjugate vaccine; 7-valent pneumococcal conjugate vaccine; Japan; PCV13; PCV7; Streptococcus pneumoniae; bacteria; capsular type; invasive pneumococcal diseases; macrolide resistance; β-lactam resistance.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Child
  • Child, Preschool
  • Drug Resistance, Bacterial / drug effects
  • Drug Resistance, Bacterial / genetics*
  • Drug Resistance, Bacterial / immunology
  • Genotype
  • Heptavalent Pneumococcal Conjugate Vaccine
  • Humans
  • Infant
  • Japan
  • Macrolides / therapeutic use
  • Penicillins / therapeutic use
  • Pneumococcal Infections / drug therapy
  • Pneumococcal Infections / immunology
  • Pneumococcal Infections / microbiology*
  • Pneumococcal Vaccines / immunology*
  • Serotyping
  • Streptococcus pneumoniae / classification*
  • Streptococcus pneumoniae / drug effects
  • Streptococcus pneumoniae / genetics*
  • Streptococcus pneumoniae / immunology
  • beta-Lactam Resistance / genetics*
  • beta-Lactam Resistance / immunology

Substances

  • Anti-Bacterial Agents
  • Heptavalent Pneumococcal Conjugate Vaccine
  • Macrolides
  • Penicillins
  • Pneumococcal Vaccines